logo
Select company
Select metric
14.34%Cash to Assets Ratio
VS
Market
66
Sector
34
Industry
21
History
63
$ 1.2Close
$ 1.1 - $ 4.29 52-Week Range
Ticker Information

Ticker

GERN

Company Name

GERON CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GERON CORP - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GERN - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 555.2M$ 79.6M14.34%
3/31/2025$ 562.45M$ 85.61M15.22%
12/31/2024$ 593.78M$ 80.88M13.62%
9/30/2024$ 444.95M$ 62.2M13.98%
6/30/2024$ 449.4M$ 118.07M26.27%
3/31/2024$ 482.07M$ 190.88M39.6%
12/31/2023$ 394.08M$ 71.14M18.05%
9/30/2023$ 413.02M$ 31.25M7.57%
6/30/2023$ 415.3M$ 57.44M13.83%
3/31/2023$ 424.88M$ 113.14M26.63%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GERON CORP's latest trailing twelve months (TTM) Cash to Assets stands at 15.86%.
  • Over the past 5 years, GERON CORP's average Cash to Assets has been 18.84%.
  • The median Cash to Assets for GERON CORP during this period was 15.72%
  • GERON CORP reached its highest Cash to Assets over the past 5 years at 39.6%.
  • The lowest Cash to Assets recorded by GERON CORP in the same timeframe 3.8%

GERON CORP's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
ZYME : ZYMEWORKS INC 24.06%AKBA : AKEBIA THERAPEUTICS INC 39.73%DAWN : DAY ONE BIOPHARMACEUTICALS INC 6.86%CRMD : CORMEDIX INC 63.07%STOK : STOKE THERAPEUTICS INC 26.41%NAGE : NIAGEN BIOSCIENCE INC 66.07%URGN : UROGEN PHARMA LTD 45.03%XNCR : XENCOR INC 5.09%DNA : GINKGO BIOWORKS HOLDINGS INC 16.54%SNDX : SYNDAX PHARMACEUTICALS INC 18.26%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for GERON CORP is calculated as follows: CashnEq [ $ 45.32M ] / Assets [ $ 285.79M ]
(=) Cash to Assets [ 15.86% ]

GERN - Cash to Assets Ratio, Last 5 years

3.8%

Minimum

Dec 31, 2020

39.6%

Maximum

Mar 31, 2024

18.84%

Average

15.72%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.84% with a standard deviation of 9.62%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.92%
average9.84%
median6.44%
std9.62%